BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24899092)

  • 1. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
    Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
    Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.
    Palareti G; Antonucci E; Mastroiacovo D; Ageno W; Pengo V; Poli D; Testa S; Tosetto A; Prandoni P
    J Thromb Haemost; 2018 Oct; 16(10):1994-2002. PubMed ID: 30059189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
    Nieto JA; Solano R; Trapero Iglesias N; Ruiz-Giménez N; Fernández-Capitán C; Valero B; Tiberio G; Bura-Riviere A; Monreal M;
    Thromb Res; 2013 Aug; 132(2):175-9. PubMed ID: 23849097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review.
    Klok FA; Kooiman J; Huisman MV; Konstantinides S; Lankeit M
    Eur Respir J; 2015 Jan; 45(1):201-10. PubMed ID: 25102964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Frei AN; Stalder O; Limacher A; Méan M; Baumgartner C; Rodondi N; Aujesky D
    Thromb Haemost; 2021 Nov; 121(11):1512-1522. PubMed ID: 33930905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study.
    Vedovati MC; Mancuso A; Pierpaoli L; Paliani U; Conti S; Ascani A; Galeotti G; Di Filippo F; Caponi C; Agnelli G; Becattini C
    Int J Cardiol; 2020 Feb; 301():167-172. PubMed ID: 31761402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States.
    Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
    J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
    Poli D; Antonucci E; Testa S; Tosetto A; Ageno W; Palareti G;
    Circulation; 2011 Aug; 124(7):824-9. PubMed ID: 21810658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
    Di Nisio M; Raskob G; Büller HR; Grosso MA; Zhang G; Winters SM; Cohen A
    Thromb Haemost; 2017 Apr; 117(4):784-793. PubMed ID: 28151543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
    Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.
    Kooistra HA; Veeger NJ; Khorsand N; Kluin-Nelemans HC; Meijer K; Piersma-Wichers M
    Thromb Haemost; 2015 Apr; 113(4):881-90. PubMed ID: 25518854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry.
    Ruíz-Giménez N; Suárez C; González R; Nieto JA; Todolí JA; Samperiz AL; Monreal M;
    Thromb Haemost; 2008 Jul; 100(1):26-31. PubMed ID: 18612534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding risks associated with vitamin K antagonists.
    Linkins LA
    Blood Rev; 2013 May; 27(3):111-8. PubMed ID: 23473948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.
    Davidson BL; Verheijen S; Lensing AW; Gebel M; Brighton TA; Lyons RM; Rehm J; Prins MH
    JAMA Intern Med; 2014 Jun; 174(6):947-53. PubMed ID: 24733305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
    Couturaud F; Kearon C
    Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding complications during anticoagulant treatment in patients with cancer.
    Kamphuisen PW; Beyer-Westendorf J
    Thromb Res; 2014 May; 133 Suppl 2():S49-55. PubMed ID: 24862146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.